← All diseases
Brain and nervous system
Progressive supranuclear palsy (PSP)
Would you like to receive a message when new research about Progressive Supranuclear Palsy (PSP) is available? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, above each publication you'll find one sentence explaining what was studied — and you'll be notified as soon as there is new research on Progressive Supranuclear Palsy (PSP). View what Premium costs.
Publications and studies (1194)
- Carbonic anhydrase inhibition ameliorates tau toxicity via enhanced tau secretion. (2025/04/01) ♡
- Utility of Cerebrospinal Fluid Transferrin Receptor per Ferritin Ratio in Progressive Supranuclear Palsy. (2025/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Heterozygous p62/SQSTM1 mutation and right temporal variant of frontotemporal dementia: Α case report. (2025/04/01) ♡
- Rapid Cognitive Deterioration in Progressive Supranuclear Palsy: A 1-Year Follow-Up Study. (2025/04/01) ♡
- Psychometric properties and clinical correlates of the Frontal Behaviour Inventory in progressive supranuclear palsy: data from the PSP-NET. (2025/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The three clap test: a window into cognitive and frontal lobe dysfunction. (2025/03/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cognitive impairment in Parkinson's disease and other parkinsonian syndromes. (2025/03/01) ♡
- Identification of metabolic progression and subtypes in progressive supranuclear palsy by PET molecular imaging. (2025/02/01) ♡
- Speech profile in different clinical PSP phenotypes: an acoustic-perceptual study. (2025/02/01) ♡
- MRI classification of progressive supranuclear palsy, Parkinson disease and controls using deep learning and machine learning algorithms for the identification of regions and tracts of interest as potential biomarkers. (2025/02/01) ♡
- Post mortem validation and mechanistic study of UCB-J in progressive supranuclear palsy patients' brains. (2025/02/01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical trial eligibility in PSP: Population representativeness and potential criteria adjustment based on PSP-NET findings. (2025/02/01) ♡
- Flattened red nucleus in progressive supranuclear palsy detected by quantitative susceptibility mapping. (2025/02/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Iron(ing) out parkinsonisms: The interplay of proteinopathy and ferroptosis in Parkinson's disease and tau-related parkinsonisms. (2025/02/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Oral applause sign in progressive supranuclear palsy. (2025/02/01) ♡
- Subcortical tau burden correlates with regional brain atrophy and plasma markers in four-repeat tauopathy parkinsonism. (2025/02/01) ♡
- RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection. (2025/01/27) ♡
- Iron deposition is associated with motor and non-motor network breakdown in parkinsonism. (2025/01/20) ♡
- Combined Assessment of Function and Survival to Demonstrate the Effect of Treatment on Progressive Supranuclear Palsy. (2025/01/01) ♡
- Chronic Musculoskeletal Pain and Risk of Incident Parkinson's Disease: A 13-Year Longitudinal Study. (2025/01/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Differences in progressive supranuclear palsy in patients of Asian ancestry? (2025/01/01) ♡
- Increased Survival in Contemporary Parkinson's Disease: A 47-Year Autopsy Study. (2025/01/01) ♡
- (18)F-Florzolotau PET Imaging Unveils Tau Pathology in Dementia with Lewy Bodies. (2025/01/01) ♡
- Dorsal Column Spinal Cord Stimulation Attenuates Brain-Spine Connectivity through Locomotion- and Visuospatial-Specific Area Activation in Progressive Freezing of Gait. (2025/01/01) ♡
- Caregiver perspectives enable accurate diagnosis of neurodegenerative disease. (2025/01/01) ♡
- Progressive Supranuclear Palsy in India: Past, Present, and Future. (2025/01/01) ♡
- Comparison of Clinical and Electrophysiologic Characteristics of Peripheral Neuropathy in Progressive Supranuclear Palsy and Parkinson's Disease: An Observational Study. (2025/01/01) ♡
- Video-Oculography for Enhancing the Diagnostic Accuracy of Early Oculomotor Dysfunction in Progressive Supranuclear Palsy. (2025/01/01) ♡
- Co-pathologies modify hippocampal protein accumulation patterns in neurodegenerative diseases. (2025/01/01) ♡
- Functional connectivity abnormalities in clinical variants of progressive supranuclear palsy. (2025/01/01) ♡
- Association between Physical Function at Discharge and Fall Frequency One Month after Discharge in Patients with Progressive Supranuclear Palsy. (2025/01/01) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy (2025-12-24) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A (2025-12-23) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. tDCS as Treatment for Motor Function (2025-12-18) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Administration of GV1001 for the Treatment of Progressive Supranuclear Palsy Who Completed Study GV1001-PSP-CL2-011 (2025-11-21) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling (2025-11-20) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Treatment of Disturbed Sleep in Progressive Supranuclear Palsy (PSP) (2025-10-23) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Study to Assess the Efficacy, Safety, and Pharmacokinetics of FNP-223 to Slow Progression of Progressive Supranuclear Palsy (PSP) (2025-10-15) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Proactive and Integrated Management and Empowerment in Parkinson's Disease (PRIME-UK): A New Model of Care (PRIME-RCT) (2025-09-29) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Neuroinflammation in FTLD (2025-09-11) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Study of the Neural Basis of Analogical Reasoning (2025-09-04) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Collection of Digital Parameters From Parts of the Neurological Examination Using an Eye Tracker (2025-08-26) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Gait Analysis Parameter and Upper Limb Evaluation in Adult Patients With Neurological or Metabolic Pathology (2025-08-22) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Speech Accessibility Project (2025-08-17) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy (2025-08-05) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Misfolded Proteins in the Skin of People With Parkinson's Disease and Other Parkinsonism (2025-07-01) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. A Pilot Study to Explore the Role of Gut Flora in Parkinson's Disease (2025-06-05) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy (2025-05-29) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Test-retest Study With [18F]PI-2620 in PSP-RS and NDC (2025-05-18) ♡
- Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Evaluation of Imaging Characteristics of [18F]PI-2620 PET in AD and PSP Patients Using High and Low Specific Activity (2025-05-18) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.